TL HAVAS - How the ‘five Ps’ can close health equity gaps
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
Thought Leadership, 14 November 2024The explosive growth of Gen AI; Liberating patient pathways; Closing health equity gaps
Boehringer Ingelheim’s Ulrike Graefe-Mody on her career path; Driving launch excellence; Top trends coming out of ESMO 2024
The challenges of environmental sustainability; ‘Causes That Count, Health’ report; Rethinking neurodegeneration
Merck’s Doina Ionescu on her professional journey; Full coverage of Communiqué 2024; Omnichannel opportunities
GSK’s Jack Harris on innovation in oncology; Harnessing creativity in a digital age; Sustainability in pharma
Interview with Ipsen’s Ioana Parsons on her new role; Celebrating comms excellence; Getting trial diversity right
Astellas' Marci English on managing the menopause; Clinigen’s Lorna Pender on treating rare diseases; the science behind behaviour change
Interview with Sanofi’s Rippon Ubhi on her new role; Optimising MS care and patient outcomes; Overcoming pharma web strategy challenges
Diversity, equity and inclusion in medical research; Marking International Day of Women and Girls in Science; Incentivising innovation in antibiotics
Interview with AstraZeneca’s Ed Piper on patient outcomes; Pharma trends and predictions for 2024; Precision medicine in chronic diseases
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
Thought Leadership, 14 November 2024Ethical content sharing and the benefits of the CLA Pharmaceutical Licence
Thought Leadership, 14 November 2024‘Patient engagement is both a process and a behaviour throughout the drug life cycle’
Thought Leadership, 14 November 2024CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
Thought Leadership, 16 October 2024Ethical content sharing and the benefits of the CLA Pharmaceutical Licence
Thought Leadership, 16 October 2024Roche and Ascidian agree to $1.8bn neurological disease partnership
Researchers identify new major cause of inflammatory bowel disease
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
The evolutionary lessons for Bayer’s management restructure
Collecting the right data in the right way for the right reasons
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
Roche and Ascidian agree to $1.8bn neurological disease partnership
Researchers identify new major cause of inflammatory bowel disease
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
The evolutionary lessons for Bayer’s management restructure
Collecting the right data in the right way for the right reasons
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
Roche and Ascidian agree to $1.8bn neurological disease partnership
Researchers identify new major cause of inflammatory bowel disease
Across almost every sector, brands are multiplying their investment in creativity
Features, 14 November 2024CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
Features, 14 November 2024Picking your omnichannel direction requires a disciplined, scientific approach
Features, 14 November 2024Iona Everson from PMGroup spoke to Doina Ionescu, managing director for the UK and Ireland at Merck, about her professional journey and experiences as a woman in the industry
Features, 14 November 2024Across almost every sector, brands are multiplying their investment in creativity
Features, 16 October 2024What value does your strategic planning add?
Communique - Marketing & Comms, 14 November 2024Inizio Engage has announced that it has merged Ashfield Event Experiences and WRG to create a new global experiential agency, Emota.
Communique - Marketing & Comms, 14 November 2024What value does your strategic planning add?
Communique - Marketing & Comms, 16 October 2024